Tur‐Fu Huang

8.5k total citations
230 papers, 7.1k citations indexed

About

Tur‐Fu Huang is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Tur‐Fu Huang has authored 230 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Genetics, 78 papers in Hematology and 72 papers in Molecular Biology. Recurrent topics in Tur‐Fu Huang's work include Venomous Animal Envenomation and Studies (93 papers), Cell Adhesion Molecules Research (65 papers) and Platelet Disorders and Treatments (61 papers). Tur‐Fu Huang is often cited by papers focused on Venomous Animal Envenomation and Studies (93 papers), Cell Adhesion Molecules Research (65 papers) and Platelet Disorders and Treatments (61 papers). Tur‐Fu Huang collaborates with scholars based in Taiwan, United States and China. Tur‐Fu Huang's co-authors include Che‐Ming Teng, Chaoho Ouyang, Stefan Niewiarowski, Hui‐Chin Peng, Feng‐Nien Ko, J. Holt, Wen‐Bin Wu, Wen‐Jeng Wang, Ching‐Hu Chung and Rong‐Sen Yang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Tur‐Fu Huang

230 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tur‐Fu Huang Taiwan 45 3.1k 2.9k 1.6k 1.6k 721 230 7.1k
Tucker Collins United States 55 6.0k 1.9× 851 0.3× 2.0k 1.2× 611 0.4× 646 0.9× 86 12.4k
Hans J. Rahmsdorf Germany 41 7.2k 2.3× 2.3k 0.8× 511 0.3× 356 0.2× 332 0.5× 79 11.5k
Ildo Nicoletti Italy 37 6.9k 2.2× 888 0.3× 346 0.2× 1.7k 1.1× 349 0.5× 101 11.6k
Manfred Brockhaus Switzerland 49 3.9k 1.3× 499 0.2× 1.0k 0.7× 485 0.3× 266 0.4× 83 10.2k
M G Low United States 52 4.6k 1.5× 673 0.2× 327 0.2× 409 0.3× 668 0.9× 93 9.3k
John David Dignam United States 22 10.2k 3.3× 2.1k 0.7× 416 0.3× 270 0.2× 293 0.4× 46 14.2k
Russell M. Lebovitz United States 26 9.9k 3.2× 2.1k 0.7× 369 0.2× 286 0.2× 287 0.4× 49 14.9k
Christer Wernstedt Sweden 45 6.1k 2.0× 919 0.3× 558 0.3× 305 0.2× 295 0.4× 85 9.5k
Robert Chiu United States 31 5.4k 1.7× 1.3k 0.4× 289 0.2× 252 0.2× 174 0.2× 66 7.9k
Hans Marquardt Germany 52 5.4k 1.8× 994 0.3× 646 0.4× 294 0.2× 237 0.3× 198 10.4k

Countries citing papers authored by Tur‐Fu Huang

Since Specialization
Citations

This map shows the geographic impact of Tur‐Fu Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tur‐Fu Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tur‐Fu Huang more than expected).

Fields of papers citing papers by Tur‐Fu Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tur‐Fu Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tur‐Fu Huang. The network helps show where Tur‐Fu Huang may publish in the future.

Co-authorship network of co-authors of Tur‐Fu Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Tur‐Fu Huang. A scholar is included among the top collaborators of Tur‐Fu Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tur‐Fu Huang. Tur‐Fu Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Weifeng, Tur‐Fu Huang, Haoliang Huang, et al.. (2025). Joule‐Heating Synthesis of High‐Entropy Oxide Nanoparticles as Sulfion Oxidation Catalysts for Efficient and Durable Hybrid Seawater Electrolysis. Advanced Functional Materials. 35(46). 3 indexed citations
2.
Sung, Pei‐Shan, Tur‐Fu Huang, & Shie‐Liang Hsieh. (2019). Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2. Nature Communications. 10(1). 2402–2402. 181 indexed citations
3.
Lien, Jin‐Cherng, et al.. (2019). A novel 2‐aminobenzimidazole‐based compound Jzu 17 exhibits anti‐angiogenesis effects by targeting VEGFR‐2 signalling. British Journal of Pharmacology. 176(20). 4034–4049. 19 indexed citations
4.
Huang, Shiu-Wen, Yufeng Jane Tseng, Shu‐Wha Lin, et al.. (2016). A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models. Thrombosis and Haemostasis. 116(8). 285–299. 11 indexed citations
5.
Lo, Shyh‐Chyi, et al.. (2006). Involvement of platelet glycoprotein Ib in platelet microparticle mediated neutrophil activation. Journal of Biomedical Science. 13(6). 787–796. 46 indexed citations
6.
Yang, Rong‐Sen, Chih‐Hsin Tang, Woei‐Jer Chuang, et al.. (2005). Inhibition of tumor formation by snake venom disintegrin. Toxicon. 45(5). 661–669. 71 indexed citations
7.
Yang, Chang‐Hao, et al.. (1996). Inhibition of Cell-Induced Vitreous Contraction by Synthetic Peptide Derived from the Collagen Receptor Binding Sequence. Journal of Ocular Pharmacology and Therapeutics. 12(3). 353–361. 2 indexed citations
8.
Chiang, Hao-Sen, et al.. (1996). Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin. European Journal of Cancer. 32(4). 715–721. 20 indexed citations
9.
Chang, M.C., Chung‐Yi Wang, & Tur‐Fu Huang. (1994). Ancrod-Formed Fibrin Stimulates Prostacyclin Production of Human Umbilical Vein Endothelial Cells via de Novo Synthesis of Cyclooxygenase. Biochemical and Biophysical Research Communications. 203(3). 1920–1926. 3 indexed citations
10.
Sheu, Joen R., et al.. (1993). Triflavin, an Arg‐Gly‐Asp‐containing Peptide, Inhibits Tumor Cell‐induced Platelet Aggregation. Japanese Journal of Cancer Research. 84(10). 1062–1071. 9 indexed citations
11.
Sheu, Joen‐Rong, Che‐Ming Teng, & Tur‐Fu Huang. (1992). Triflavin, an RGD-containing antiplatelet peptide, binds to GPIIIa of ADP-stimulated platelets. Biochemical and Biophysical Research Communications. 189(2). 1236–1242. 51 indexed citations
12.
Teng, Che‐Ming, et al.. (1992). Ca++ -channel Blocking Effects of Three Coumarin Compounds, Isolated from Citrus Grandis, in Rat Thoracic Aorta. 7(2). 115–120. 3 indexed citations
13.
Sheu, Joen R., et al.. (1992). Triflavin, an Arg‐Gly‐Asp‐containing Antiplatelet Peptide Inhibits Cell‐substratum Adhesion and Melanoma Cell‐induced Lung Colonization. Japanese Journal of Cancer Research. 83(8). 885–893. 40 indexed citations
14.
Huang, Tur‐Fu, et al.. (1991). Purification and characterization of an antiplatelet peptide, arietin, from Bitis arietans venom. Biochimica et Biophysica Acta (BBA) - General Subjects. 1074(1). 136–143. 17 indexed citations
15.
Teng, Che‐Ming, et al.. (1991). Dicentrine, a natural vascular α1‐adrenoceptor antagonist, isolated from Lindera megaphylla. British Journal of Pharmacology. 104(3). 651–656. 44 indexed citations
16.
Teng, Che‐Ming, et al.. (1988). Inhibition of platelet aggregation by apigenin from apium graveolens. 3(2). 85–90. 21 indexed citations
17.
Teng, Che‐Ming, et al.. (1988). Two antiplatelet agents from. Thrombosis Research. 50(6). 757–765. 141 indexed citations
18.
Huang, Tur‐Fu. (1979). THE ROLE OF THE BULBAR RETICULAR FORMATION IN THE INHIBITION OF VISCERAL PAIN BY ACUPUNCTURE. 1 indexed citations
19.
Huang, Tur‐Fu. (1973). THE ACTION POTENTIAL OF THE MYOCARDIAL CELLS OF THE GOLDEN CARP. The Japanese Journal of Physiology. 23(5). 529–540. 9 indexed citations
20.
Huang, Tur‐Fu. (1969). Effect of Antiarrhythmic Agents on Cardiac Arrhythmias Induced by the Posterior Hypothalamus Stimulation in Cats. The Chinese Journal of Physiology. 20(3). 197–204. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026